Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Prostatic Neoplasms 37Carcinoma, Hepatocellular 3Stage II Prostate Adenocarcinoma 1Prostate-specific Membrane Antigen 1Ovarian Neoplasms 1Carcinoma, Lobular 1Carcinoma, Adenoid Cystic 1Biochemically Recurrent Prostate Carcinoma 1

Interventions

Sorafenib 121Nivolumab 36pembrolizumab 32Bevacizumab 28lenvatinib 27Doxorubicin 23Radiosurgery 21Radiofrequency Ablation 20Oxaliplatin 20Hepatectomy 18Fluorouracil 15Capecitabine 15Magnetic Resonance Spectroscopy 14atezolizumab 13Leucovorin 13Cisplatin 13Gemcitabine 11Erlotinib Hydrochloride 11tislelizumab 9Sirolimus 9Radiotherapy 9Irinotecan 9Ipilimumab 9cabozantinib 8Liver Transplantation 8regorafenib 7Ramucirumab 7Folfox protocol 7Embolization, Therapeutic 7sintilimab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Carcinoma, Hepatocellular × gallium 68 PSMA-11 × Clear all
NCT05176223 2026-02-05

68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer

Mayo Clinic

Phase 2 Completed
29 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04762888 2025-10-31

68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer

Mayo Clinic

Phase 2 Completed
52 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04310540 2024-09-19

PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer

Mayo Clinic

Phase EARLY_PHASE1 Completed
42 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡